nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—AGTR1—atherosclerosis	0.382	1	CbGaD
Candesartan—UGT1A3—Ezetimibe—atherosclerosis	0.109	0.233	CbGbCtD
Candesartan—UGT1A3—Simvastatin—atherosclerosis	0.102	0.217	CbGbCtD
Candesartan—UGT1A3—Lovastatin—atherosclerosis	0.0995	0.212	CbGbCtD
Candesartan—CYP2C8—Simvastatin—atherosclerosis	0.0186	0.0397	CbGbCtD
Candesartan—CYP2C8—Lovastatin—atherosclerosis	0.0182	0.0389	CbGbCtD
Candesartan—CYP2C8—Pravastatin—atherosclerosis	0.0182	0.0389	CbGbCtD
Candesartan—CYP2C9—Rosuvastatin—atherosclerosis	0.014	0.0298	CbGbCtD
Candesartan—ABCB1—Ezetimibe—atherosclerosis	0.0136	0.0289	CbGbCtD
Candesartan—CYP2C9—Simvastatin—atherosclerosis	0.013	0.0277	CbGbCtD
Candesartan—CYP2C9—Lovastatin—atherosclerosis	0.0127	0.0271	CbGbCtD
Candesartan—CYP2C9—Pravastatin—atherosclerosis	0.0127	0.0271	CbGbCtD
Candesartan—ABCB1—Simvastatin—atherosclerosis	0.0126	0.0269	CbGbCtD
Candesartan—ABCB1—Lovastatin—atherosclerosis	0.0123	0.0263	CbGbCtD
Candesartan—ABCB1—Pravastatin—atherosclerosis	0.0123	0.0263	CbGbCtD
Candesartan—Nephropathy—Rosuvastatin—atherosclerosis	0.00218	0.0246	CcSEcCtD
Candesartan—Creatine phosphokinase increased—Rosuvastatin—atherosclerosis	0.00198	0.0223	CcSEcCtD
Candesartan—Creatine phosphokinase increased—Lovastatin—atherosclerosis	0.00167	0.0189	CcSEcCtD
Candesartan—Creatine phosphokinase increased—Ezetimibe—atherosclerosis	0.00164	0.0185	CcSEcCtD
Candesartan—Creatine phosphokinase increased—Simvastatin—atherosclerosis	0.00157	0.0177	CcSEcCtD
Candesartan—Blood creatine phosphokinase increased—Rosuvastatin—atherosclerosis	0.00151	0.017	CcSEcCtD
Candesartan—Transaminases increased—Lovastatin—atherosclerosis	0.00145	0.0163	CcSEcCtD
Candesartan—Transaminases increased—Ezetimibe—atherosclerosis	0.00142	0.016	CcSEcCtD
Candesartan—Creatine phosphokinase increased—Pravastatin—atherosclerosis	0.00142	0.016	CcSEcCtD
Candesartan—AGTR1—artery—atherosclerosis	0.00141	0.146	CbGeAlD
Candesartan—Transaminases increased—Simvastatin—atherosclerosis	0.00135	0.0153	CcSEcCtD
Candesartan—Blood creatine phosphokinase increased—Lovastatin—atherosclerosis	0.00128	0.0144	CcSEcCtD
Candesartan—Blood creatine phosphokinase increased—Ezetimibe—atherosclerosis	0.00125	0.0142	CcSEcCtD
Candesartan—Transaminases increased—Pravastatin—atherosclerosis	0.00122	0.0138	CcSEcCtD
Candesartan—Blood creatine phosphokinase increased—Simvastatin—atherosclerosis	0.0012	0.0135	CcSEcCtD
Candesartan—AGTR1—endothelium—atherosclerosis	0.00119	0.124	CbGeAlD
Candesartan—Rhabdomyolysis—Rosuvastatin—atherosclerosis	0.00117	0.0133	CcSEcCtD
Candesartan—AGTR1—blood vessel—atherosclerosis	0.0011	0.114	CbGeAlD
Candesartan—Blood creatine phosphokinase increased—Pravastatin—atherosclerosis	0.00108	0.0122	CcSEcCtD
Candesartan—Rhabdomyolysis—Lovastatin—atherosclerosis	0.000995	0.0112	CcSEcCtD
Candesartan—Rhabdomyolysis—Ezetimibe—atherosclerosis	0.000976	0.011	CcSEcCtD
Candesartan—Rhabdomyolysis—Simvastatin—atherosclerosis	0.00093	0.0105	CcSEcCtD
Candesartan—Rhabdomyolysis—Niacin—atherosclerosis	0.000854	0.00965	CcSEcCtD
Candesartan—Gastroenteritis—Rosuvastatin—atherosclerosis	0.000851	0.0096	CcSEcCtD
Candesartan—Rhabdomyolysis—Pravastatin—atherosclerosis	0.000841	0.0095	CcSEcCtD
Candesartan—Hyperuricaemia—Niacin—atherosclerosis	0.000815	0.0092	CcSEcCtD
Candesartan—Pranlukast—NFKB1—atherosclerosis	0.000814	0.154	CrCbGaD
Candesartan—Blood uric acid increased—Niacin—atherosclerosis	0.00077	0.00869	CcSEcCtD
Candesartan—Azilsartan medoxomil—AGTR1—atherosclerosis	0.000745	0.141	CrCbGaD
Candesartan—UGT1A3—liver—atherosclerosis	0.00071	0.0739	CbGeAlD
Candesartan—Forasartan—AGTR1—atherosclerosis	0.000692	0.131	CrCbGaD
Candesartan—Bronchitis—Rosuvastatin—atherosclerosis	0.000627	0.00708	CcSEcCtD
Candesartan—PTGS1—artery—atherosclerosis	0.000619	0.0644	CbGeAlD
Candesartan—AGTR1—connective tissue—atherosclerosis	0.000562	0.0585	CbGeAlD
Candesartan—Haematuria—Rosuvastatin—atherosclerosis	0.000554	0.00625	CcSEcCtD
Candesartan—Sinusitis—Rosuvastatin—atherosclerosis	0.000545	0.00615	CcSEcCtD
Candesartan—PTGS1—endothelium—atherosclerosis	0.000523	0.0544	CbGeAlD
Candesartan—Rhinitis—Rosuvastatin—atherosclerosis	0.000523	0.0059	CcSEcCtD
Candesartan—Hepatitis—Rosuvastatin—atherosclerosis	0.000522	0.00589	CcSEcCtD
Candesartan—Pharyngitis—Rosuvastatin—atherosclerosis	0.000518	0.00584	CcSEcCtD
Candesartan—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.000503	0.00568	CcSEcCtD
Candesartan—Bronchitis—Simvastatin—atherosclerosis	0.000497	0.00561	CcSEcCtD
Candesartan—AGTR1—cardiovascular system—atherosclerosis	0.000489	0.0509	CbGeAlD
Candesartan—PTGS1—blood vessel—atherosclerosis	0.000482	0.0502	CbGeAlD
Candesartan—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00048	0.00542	CcSEcCtD
Candesartan—Angina pectoris—Niacin—atherosclerosis	0.000462	0.00522	CcSEcCtD
Candesartan—Sinusitis—Lovastatin—atherosclerosis	0.000462	0.00522	CcSEcCtD
Candesartan—Mental disorder—Rosuvastatin—atherosclerosis	0.000457	0.00516	CcSEcCtD
Candesartan—Bronchitis—Niacin—atherosclerosis	0.000456	0.00515	CcSEcCtD
Candesartan—Sweating increased—Pravastatin—atherosclerosis	0.000455	0.00514	CcSEcCtD
Candesartan—Angina pectoris—Pravastatin—atherosclerosis	0.000455	0.00514	CcSEcCtD
Candesartan—Sinusitis—Ezetimibe—atherosclerosis	0.000453	0.00512	CcSEcCtD
Candesartan—Hepatitis—Lovastatin—atherosclerosis	0.000442	0.00499	CcSEcCtD
Candesartan—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.000434	0.0049	CcSEcCtD
Candesartan—Hepatitis—Ezetimibe—atherosclerosis	0.000433	0.00489	CcSEcCtD
Candesartan—Sinusitis—Simvastatin—atherosclerosis	0.000432	0.00488	CcSEcCtD
Candesartan—AGTR1—adipose tissue—atherosclerosis	0.000432	0.0449	CbGeAlD
Candesartan—Pharyngitis—Ezetimibe—atherosclerosis	0.00043	0.00486	CcSEcCtD
Candesartan—Oedema peripheral—Ezetimibe—atherosclerosis	0.000427	0.00482	CcSEcCtD
Candesartan—Tasosartan—AGTR1—atherosclerosis	0.000419	0.0793	CrCbGaD
Candesartan—Angioedema—Rosuvastatin—atherosclerosis	0.000415	0.00468	CcSEcCtD
Candesartan—Hepatitis—Simvastatin—atherosclerosis	0.000413	0.00467	CcSEcCtD
Candesartan—Irbesartan—EDNRA—atherosclerosis	0.000413	0.078	CrCbGaD
Candesartan—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00041	0.00463	CcSEcCtD
Candesartan—Myocardial infarction—Pravastatin—atherosclerosis	0.000408	0.00461	CcSEcCtD
Candesartan—Cough—Rosuvastatin—atherosclerosis	0.000396	0.00447	CcSEcCtD
Candesartan—Sinusitis—Pravastatin—atherosclerosis	0.000391	0.00441	CcSEcCtD
Candesartan—Arthralgia—Rosuvastatin—atherosclerosis	0.000387	0.00436	CcSEcCtD
Candesartan—Myalgia—Rosuvastatin—atherosclerosis	0.000387	0.00436	CcSEcCtD
Candesartan—Haemoglobin—Niacin—atherosclerosis	0.000382	0.00431	CcSEcCtD
Candesartan—Rhinitis—Niacin—atherosclerosis	0.000381	0.0043	CcSEcCtD
Candesartan—Mental disorder—Ezetimibe—atherosclerosis	0.00038	0.00429	CcSEcCtD
Candesartan—Haemorrhage—Niacin—atherosclerosis	0.00038	0.00429	CcSEcCtD
Candesartan—Hepatitis—Niacin—atherosclerosis	0.00038	0.00429	CcSEcCtD
Candesartan—Malnutrition—Ezetimibe—atherosclerosis	0.000377	0.00426	CcSEcCtD
Candesartan—Rhinitis—Pravastatin—atherosclerosis	0.000375	0.00423	CcSEcCtD
Candesartan—Oedema peripheral—Niacin—atherosclerosis	0.000374	0.00422	CcSEcCtD
Candesartan—Hepatitis—Pravastatin—atherosclerosis	0.000374	0.00422	CcSEcCtD
Candesartan—Back pain—Lovastatin—atherosclerosis	0.000372	0.0042	CcSEcCtD
Candesartan—Pharyngitis—Pravastatin—atherosclerosis	0.000371	0.00419	CcSEcCtD
Candesartan—Back pain—Ezetimibe—atherosclerosis	0.000365	0.00412	CcSEcCtD
Candesartan—Valsartan—AGTR1—atherosclerosis	0.000364	0.0687	CrCbGaD
Candesartan—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000363	0.0041	CcSEcCtD
Candesartan—Mental disorder—Simvastatin—atherosclerosis	0.000362	0.00409	CcSEcCtD
Candesartan—Olmesartan—AGTR1—atherosclerosis	0.000354	0.067	CrCbGaD
Candesartan—Angioedema—Lovastatin—atherosclerosis	0.000352	0.00397	CcSEcCtD
Candesartan—Anaemia—Ezetimibe—atherosclerosis	0.000349	0.00394	CcSEcCtD
Candesartan—Vertigo—Lovastatin—atherosclerosis	0.000346	0.0039	CcSEcCtD
Candesartan—Angioedema—Ezetimibe—atherosclerosis	0.000345	0.00389	CcSEcCtD
Candesartan—Leukopenia—Lovastatin—atherosclerosis	0.000344	0.00389	CcSEcCtD
Candesartan—Telmisartan—AGTR1—atherosclerosis	0.000342	0.0646	CrCbGaD
Candesartan—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000338	0.00381	CcSEcCtD
Candesartan—Palpitations—Ezetimibe—atherosclerosis	0.000333	0.00377	CcSEcCtD
Candesartan—Paraesthesia—Rosuvastatin—atherosclerosis	0.000333	0.00376	CcSEcCtD
Candesartan—Anaemia—Simvastatin—atherosclerosis	0.000333	0.00376	CcSEcCtD
Candesartan—Malnutrition—Niacin—atherosclerosis	0.00033	0.00373	CcSEcCtD
Candesartan—Cough—Ezetimibe—atherosclerosis	0.000329	0.00372	CcSEcCtD
Candesartan—Angioedema—Simvastatin—atherosclerosis	0.000329	0.00371	CcSEcCtD
Candesartan—Arthralgia—Lovastatin—atherosclerosis	0.000328	0.0037	CcSEcCtD
Candesartan—Myalgia—Lovastatin—atherosclerosis	0.000328	0.0037	CcSEcCtD
Candesartan—Chest pain—Lovastatin—atherosclerosis	0.000328	0.0037	CcSEcCtD
Candesartan—Anxiety—Lovastatin—atherosclerosis	0.000326	0.00369	CcSEcCtD
Candesartan—Dyspepsia—Rosuvastatin—atherosclerosis	0.000326	0.00368	CcSEcCtD
Candesartan—Hypertension—Ezetimibe—atherosclerosis	0.000326	0.00368	CcSEcCtD
Candesartan—Vertigo—Simvastatin—atherosclerosis	0.000323	0.00365	CcSEcCtD
Candesartan—Leukopenia—Simvastatin—atherosclerosis	0.000322	0.00364	CcSEcCtD
Candesartan—Arthralgia—Ezetimibe—atherosclerosis	0.000321	0.00363	CcSEcCtD
Candesartan—Myalgia—Ezetimibe—atherosclerosis	0.000321	0.00363	CcSEcCtD
Candesartan—Chest pain—Ezetimibe—atherosclerosis	0.000321	0.00363	CcSEcCtD
Candesartan—Thrombocytopenia—Lovastatin—atherosclerosis	0.000307	0.00347	CcSEcCtD
Candesartan—Myalgia—Simvastatin—atherosclerosis	0.000306	0.00346	CcSEcCtD
Candesartan—Chest pain—Simvastatin—atherosclerosis	0.000306	0.00346	CcSEcCtD
Candesartan—Arthralgia—Simvastatin—atherosclerosis	0.000306	0.00346	CcSEcCtD
Candesartan—Anxiety—Simvastatin—atherosclerosis	0.000305	0.00345	CcSEcCtD
Candesartan—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000303	0.00342	CcSEcCtD
Candesartan—AGTR1—liver—atherosclerosis	0.000303	0.0315	CbGeAlD
Candesartan—Angioedema—Niacin—atherosclerosis	0.000302	0.00341	CcSEcCtD
Candesartan—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000302	0.0034	CcSEcCtD
Candesartan—Anaemia—Pravastatin—atherosclerosis	0.000301	0.0034	CcSEcCtD
Candesartan—Angioedema—Pravastatin—atherosclerosis	0.000297	0.00336	CcSEcCtD
Candesartan—Vertigo—Niacin—atherosclerosis	0.000297	0.00335	CcSEcCtD
Candesartan—Leukopenia—Niacin—atherosclerosis	0.000296	0.00334	CcSEcCtD
Candesartan—Urticaria—Rosuvastatin—atherosclerosis	0.000294	0.00332	CcSEcCtD
Candesartan—Abdominal pain—Rosuvastatin—atherosclerosis	0.000293	0.00331	CcSEcCtD
Candesartan—Vertigo—Pravastatin—atherosclerosis	0.000292	0.0033	CcSEcCtD
Candesartan—Palpitations—Niacin—atherosclerosis	0.000292	0.0033	CcSEcCtD
Candesartan—Leukopenia—Pravastatin—atherosclerosis	0.000291	0.00329	CcSEcCtD
Candesartan—Cough—Niacin—atherosclerosis	0.000288	0.00326	CcSEcCtD
Candesartan—Thrombocytopenia—Simvastatin—atherosclerosis	0.000288	0.00325	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000286	0.00323	CcSEcCtD
Candesartan—ABCB1—blood vessel—atherosclerosis	0.000285	0.0297	CbGeAlD
Candesartan—Cough—Pravastatin—atherosclerosis	0.000284	0.00321	CcSEcCtD
Candesartan—Paraesthesia—Lovastatin—atherosclerosis	0.000282	0.00318	CcSEcCtD
Candesartan—Arthralgia—Niacin—atherosclerosis	0.000281	0.00318	CcSEcCtD
Candesartan—Myalgia—Niacin—atherosclerosis	0.000281	0.00318	CcSEcCtD
Candesartan—Hypertension—Pravastatin—atherosclerosis	0.000281	0.00317	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000281	0.00317	CcSEcCtD
Candesartan—Dyspnoea—Lovastatin—atherosclerosis	0.00028	0.00316	CcSEcCtD
Candesartan—Myalgia—Pravastatin—atherosclerosis	0.000277	0.00313	CcSEcCtD
Candesartan—Chest pain—Pravastatin—atherosclerosis	0.000277	0.00313	CcSEcCtD
Candesartan—Arthralgia—Pravastatin—atherosclerosis	0.000277	0.00313	CcSEcCtD
Candesartan—Paraesthesia—Ezetimibe—atherosclerosis	0.000277	0.00312	CcSEcCtD
Candesartan—Dyspepsia—Lovastatin—atherosclerosis	0.000276	0.00312	CcSEcCtD
Candesartan—Anxiety—Pravastatin—atherosclerosis	0.000276	0.00312	CcSEcCtD
Candesartan—Irbesartan—AGTR1—atherosclerosis	0.000276	0.0521	CrCbGaD
Candesartan—Dyspnoea—Ezetimibe—atherosclerosis	0.000275	0.0031	CcSEcCtD
Candesartan—Dyspepsia—Ezetimibe—atherosclerosis	0.000271	0.00306	CcSEcCtD
Candesartan—Fatigue—Lovastatin—atherosclerosis	0.000271	0.00306	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000268	0.00302	CcSEcCtD
Candesartan—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000266	0.003	CcSEcCtD
Candesartan—Asthenia—Rosuvastatin—atherosclerosis	0.000266	0.003	CcSEcCtD
Candesartan—Fatigue—Ezetimibe—atherosclerosis	0.000266	0.003	CcSEcCtD
Candesartan—Paraesthesia—Simvastatin—atherosclerosis	0.000264	0.00298	CcSEcCtD
Candesartan—Tachycardia—Niacin—atherosclerosis	0.000263	0.00297	CcSEcCtD
Candesartan—Pruritus—Rosuvastatin—atherosclerosis	0.000262	0.00296	CcSEcCtD
Candesartan—Dyspnoea—Simvastatin—atherosclerosis	0.000262	0.00296	CcSEcCtD
Candesartan—Hyperhidrosis—Niacin—atherosclerosis	0.000261	0.00294	CcSEcCtD
Candesartan—Thrombocytopenia—Pravastatin—atherosclerosis	0.00026	0.00294	CcSEcCtD
Candesartan—Dyspepsia—Simvastatin—atherosclerosis	0.000259	0.00292	CcSEcCtD
Candesartan—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000257	0.0029	CcSEcCtD
Candesartan—Hyperhidrosis—Pravastatin—atherosclerosis	0.000257	0.0029	CcSEcCtD
Candesartan—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000254	0.00286	CcSEcCtD
Candesartan—Diarrhoea—Rosuvastatin—atherosclerosis	0.000254	0.00286	CcSEcCtD
Candesartan—Fatigue—Simvastatin—atherosclerosis	0.000253	0.00286	CcSEcCtD
Candesartan—Hypotension—Niacin—atherosclerosis	0.000252	0.00285	CcSEcCtD
Candesartan—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000252	0.00284	CcSEcCtD
Candesartan—Pranlukast—TNF—atherosclerosis	0.00025	0.0472	CrCbGaD
Candesartan—Urticaria—Lovastatin—atherosclerosis	0.000249	0.00282	CcSEcCtD
Candesartan—Abdominal pain—Lovastatin—atherosclerosis	0.000248	0.0028	CcSEcCtD
Candesartan—Body temperature increased—Lovastatin—atherosclerosis	0.000248	0.0028	CcSEcCtD
Candesartan—PTGS1—connective tissue—atherosclerosis	0.000247	0.0257	CbGeAlD
Candesartan—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000246	0.00277	CcSEcCtD
Candesartan—Dizziness—Rosuvastatin—atherosclerosis	0.000245	0.00277	CcSEcCtD
Candesartan—Urticaria—Ezetimibe—atherosclerosis	0.000245	0.00276	CcSEcCtD
Candesartan—Abdominal pain—Ezetimibe—atherosclerosis	0.000243	0.00275	CcSEcCtD
Candesartan—Body temperature increased—Ezetimibe—atherosclerosis	0.000243	0.00275	CcSEcCtD
Candesartan—Paraesthesia—Niacin—atherosclerosis	0.000242	0.00273	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000242	0.00273	CcSEcCtD
Candesartan—Dyspnoea—Niacin—atherosclerosis	0.00024	0.00271	CcSEcCtD
Candesartan—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00024	0.00271	CcSEcCtD
Candesartan—Somnolence—Niacin—atherosclerosis	0.00024	0.00271	CcSEcCtD
Candesartan—Paraesthesia—Pravastatin—atherosclerosis	0.000238	0.00269	CcSEcCtD
Candesartan—Dyspepsia—Niacin—atherosclerosis	0.000237	0.00268	CcSEcCtD
Candesartan—Dyspnoea—Pravastatin—atherosclerosis	0.000237	0.00267	CcSEcCtD
Candesartan—CYP2C9—cardiovascular system—atherosclerosis	0.000236	0.0245	CbGeAlD
Candesartan—Dyspepsia—Pravastatin—atherosclerosis	0.000234	0.00264	CcSEcCtD
Candesartan—Rash—Rosuvastatin—atherosclerosis	0.000234	0.00264	CcSEcCtD
Candesartan—Dermatitis—Rosuvastatin—atherosclerosis	0.000233	0.00264	CcSEcCtD
Candesartan—Urticaria—Simvastatin—atherosclerosis	0.000233	0.00263	CcSEcCtD
Candesartan—Gastrointestinal disorder—Niacin—atherosclerosis	0.000233	0.00263	CcSEcCtD
Candesartan—Abdominal pain—Simvastatin—atherosclerosis	0.000232	0.00262	CcSEcCtD
Candesartan—Body temperature increased—Simvastatin—atherosclerosis	0.000232	0.00262	CcSEcCtD
Candesartan—Headache—Rosuvastatin—atherosclerosis	0.000232	0.00262	CcSEcCtD
Candesartan—Fatigue—Pravastatin—atherosclerosis	0.000229	0.00259	CcSEcCtD
Candesartan—Asthenia—Lovastatin—atherosclerosis	0.000225	0.00254	CcSEcCtD
Candesartan—Pruritus—Lovastatin—atherosclerosis	0.000222	0.00251	CcSEcCtD
Candesartan—Asthenia—Ezetimibe—atherosclerosis	0.000221	0.0025	CcSEcCtD
Candesartan—Gastrointestinal pain—Niacin—atherosclerosis	0.000221	0.00249	CcSEcCtD
Candesartan—Nausea—Rosuvastatin—atherosclerosis	0.00022	0.00249	CcSEcCtD
Candesartan—Pruritus—Ezetimibe—atherosclerosis	0.000218	0.00246	CcSEcCtD
Candesartan—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000217	0.00245	CcSEcCtD
Candesartan—Telmisartan—PPARG—atherosclerosis	0.000215	0.0407	CrCbGaD
Candesartan—PTGS1—cardiovascular system—atherosclerosis	0.000215	0.0224	CbGeAlD
Candesartan—Diarrhoea—Lovastatin—atherosclerosis	0.000215	0.00243	CcSEcCtD
Candesartan—Urticaria—Niacin—atherosclerosis	0.000214	0.00242	CcSEcCtD
Candesartan—Body temperature increased—Niacin—atherosclerosis	0.000213	0.00241	CcSEcCtD
Candesartan—Abdominal pain—Niacin—atherosclerosis	0.000213	0.00241	CcSEcCtD
Candesartan—Urticaria—Pravastatin—atherosclerosis	0.000211	0.00238	CcSEcCtD
Candesartan—Asthenia—Simvastatin—atherosclerosis	0.000211	0.00238	CcSEcCtD
Candesartan—Diarrhoea—Ezetimibe—atherosclerosis	0.000211	0.00238	CcSEcCtD
Candesartan—Abdominal pain—Pravastatin—atherosclerosis	0.00021	0.00237	CcSEcCtD
Candesartan—Body temperature increased—Pravastatin—atherosclerosis	0.00021	0.00237	CcSEcCtD
Candesartan—Pruritus—Simvastatin—atherosclerosis	0.000208	0.00235	CcSEcCtD
Candesartan—Dizziness—Lovastatin—atherosclerosis	0.000208	0.00234	CcSEcCtD
Candesartan—Dizziness—Ezetimibe—atherosclerosis	0.000204	0.0023	CcSEcCtD
Candesartan—Diarrhoea—Simvastatin—atherosclerosis	0.000201	0.00227	CcSEcCtD
Candesartan—Vomiting—Lovastatin—atherosclerosis	0.0002	0.00225	CcSEcCtD
Candesartan—Rash—Lovastatin—atherosclerosis	0.000198	0.00224	CcSEcCtD
Candesartan—Dermatitis—Lovastatin—atherosclerosis	0.000198	0.00223	CcSEcCtD
Candesartan—Headache—Lovastatin—atherosclerosis	0.000197	0.00222	CcSEcCtD
Candesartan—Vomiting—Ezetimibe—atherosclerosis	0.000196	0.00221	CcSEcCtD
Candesartan—Dizziness—Simvastatin—atherosclerosis	0.000194	0.00219	CcSEcCtD
Candesartan—Rash—Ezetimibe—atherosclerosis	0.000194	0.00219	CcSEcCtD
Candesartan—Dermatitis—Ezetimibe—atherosclerosis	0.000194	0.00219	CcSEcCtD
Candesartan—Asthenia—Niacin—atherosclerosis	0.000193	0.00218	CcSEcCtD
Candesartan—Headache—Ezetimibe—atherosclerosis	0.000193	0.00218	CcSEcCtD
Candesartan—Pruritus—Niacin—atherosclerosis	0.000191	0.00215	CcSEcCtD
Candesartan—Asthenia—Pravastatin—atherosclerosis	0.000191	0.00215	CcSEcCtD
Candesartan—PTGS1—adipose tissue—atherosclerosis	0.00019	0.0197	CbGeAlD
Candesartan—Pruritus—Pravastatin—atherosclerosis	0.000188	0.00212	CcSEcCtD
Candesartan—Vomiting—Simvastatin—atherosclerosis	0.000187	0.00211	CcSEcCtD
Candesartan—Nausea—Lovastatin—atherosclerosis	0.000187	0.00211	CcSEcCtD
Candesartan—Rash—Simvastatin—atherosclerosis	0.000185	0.00209	CcSEcCtD
Candesartan—Dermatitis—Simvastatin—atherosclerosis	0.000185	0.00209	CcSEcCtD
Candesartan—Diarrhoea—Niacin—atherosclerosis	0.000185	0.00208	CcSEcCtD
Candesartan—Headache—Simvastatin—atherosclerosis	0.000184	0.00208	CcSEcCtD
Candesartan—Nausea—Ezetimibe—atherosclerosis	0.000183	0.00207	CcSEcCtD
Candesartan—Diarrhoea—Pravastatin—atherosclerosis	0.000182	0.00205	CcSEcCtD
Candesartan—Dizziness—Niacin—atherosclerosis	0.000178	0.00201	CcSEcCtD
Candesartan—Losartan—AGTR1—atherosclerosis	0.000178	0.0336	CrCbGaD
Candesartan—Dizziness—Pravastatin—atherosclerosis	0.000176	0.00198	CcSEcCtD
Candesartan—Nausea—Simvastatin—atherosclerosis	0.000174	0.00197	CcSEcCtD
Candesartan—Vomiting—Niacin—atherosclerosis	0.000171	0.00194	CcSEcCtD
Candesartan—Rash—Niacin—atherosclerosis	0.00017	0.00192	CcSEcCtD
Candesartan—Dermatitis—Niacin—atherosclerosis	0.00017	0.00192	CcSEcCtD
Candesartan—Headache—Niacin—atherosclerosis	0.000169	0.00191	CcSEcCtD
Candesartan—Vomiting—Pravastatin—atherosclerosis	0.000169	0.00191	CcSEcCtD
Candesartan—Rash—Pravastatin—atherosclerosis	0.000167	0.00189	CcSEcCtD
Candesartan—Dermatitis—Pravastatin—atherosclerosis	0.000167	0.00189	CcSEcCtD
Candesartan—Headache—Pravastatin—atherosclerosis	0.000166	0.00188	CcSEcCtD
Candesartan—CYP2C8—liver—atherosclerosis	0.000164	0.0171	CbGeAlD
Candesartan—Nausea—Niacin—atherosclerosis	0.00016	0.00181	CcSEcCtD
Candesartan—Nausea—Pravastatin—atherosclerosis	0.000158	0.00178	CcSEcCtD
Candesartan—CYP2C9—liver—atherosclerosis	0.000146	0.0152	CbGeAlD
Candesartan—ABCB1—cardiovascular system—atherosclerosis	0.000127	0.0132	CbGeAlD
Candesartan—ABCB1—adipose tissue—atherosclerosis	0.000112	0.0117	CbGeAlD
Candesartan—Losartan—ACE—atherosclerosis	0.000103	0.0194	CrCbGaD
Candesartan—Valsartan—ALB—atherosclerosis	8.61e-05	0.0163	CrCbGaD
Candesartan—ABCB1—liver—atherosclerosis	7.87e-05	0.00818	CbGeAlD
Candesartan—Losartan—ALB—atherosclerosis	4.2e-05	0.00794	CrCbGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	1.47e-05	0.000322	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CD36—atherosclerosis	1.47e-05	0.000322	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—APOB—atherosclerosis	1.46e-05	0.00032	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—PLAT—atherosclerosis	1.45e-05	0.000319	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CXCL8—atherosclerosis	1.45e-05	0.000318	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—LCAT—atherosclerosis	1.44e-05	0.000315	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—FABP4—atherosclerosis	1.44e-05	0.000315	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—EDN1—atherosclerosis	1.44e-05	0.000315	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—NAMPT—atherosclerosis	1.43e-05	0.000315	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCL5—atherosclerosis	1.42e-05	0.000313	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.42e-05	0.000313	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—LIPC—atherosclerosis	1.42e-05	0.000313	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—APOC3—atherosclerosis	1.41e-05	0.000311	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOA4—atherosclerosis	1.41e-05	0.00031	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—LDLR—atherosclerosis	1.41e-05	0.000309	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—LPL—atherosclerosis	1.39e-05	0.000306	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—MTHFR—atherosclerosis	1.39e-05	0.000305	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP7A1—atherosclerosis	1.38e-05	0.000304	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CETP—atherosclerosis	1.37e-05	0.000302	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PPARA—atherosclerosis	1.36e-05	0.000299	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PRKCG—atherosclerosis	1.35e-05	0.000297	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ABCG1—atherosclerosis	1.33e-05	0.000292	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.32e-05	0.00029	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—AGT—atherosclerosis	1.32e-05	0.00029	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SPP1—atherosclerosis	1.32e-05	0.00029	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—SCARB1—atherosclerosis	1.32e-05	0.000289	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CXCL8—atherosclerosis	1.31e-05	0.000288	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	1.31e-05	0.000288	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	1.31e-05	0.000287	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—APOE—atherosclerosis	1.29e-05	0.000284	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	1.29e-05	0.000283	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CAV1—atherosclerosis	1.28e-05	0.000281	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.28e-05	0.000281	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP27A1—atherosclerosis	1.28e-05	0.000281	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—APOA1—atherosclerosis	1.28e-05	0.000281	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.26e-05	0.000277	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—FABP4—atherosclerosis	1.25e-05	0.000275	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—LCAT—atherosclerosis	1.25e-05	0.000275	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ABCG1—atherosclerosis	1.24e-05	0.000273	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—HMGCR—atherosclerosis	1.24e-05	0.000273	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—PLG—atherosclerosis	1.24e-05	0.000272	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1.23e-05	0.00027	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOA4—atherosclerosis	1.23e-05	0.00027	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PDGFB—atherosclerosis	1.22e-05	0.000268	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALOX15—atherosclerosis	1.21e-05	0.000266	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOA2—atherosclerosis	1.21e-05	0.000266	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PLA2G2A—atherosclerosis	1.21e-05	0.000266	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALOX5AP—atherosclerosis	1.21e-05	0.000266	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP7A1—atherosclerosis	1.21e-05	0.000265	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ABCG5—atherosclerosis	1.2e-05	0.000263	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	1.2e-05	0.000263	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—AGT—atherosclerosis	1.19e-05	0.000262	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	1.19e-05	0.000261	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—LCAT—atherosclerosis	1.17e-05	0.000257	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—FABP4—atherosclerosis	1.17e-05	0.000257	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—LEP—atherosclerosis	1.17e-05	0.000256	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—APOE—atherosclerosis	1.17e-05	0.000256	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PIK3CG—atherosclerosis	1.17e-05	0.000256	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—LPA—atherosclerosis	1.16e-05	0.000254	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CAV1—atherosclerosis	1.16e-05	0.000254	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—APOA1—atherosclerosis	1.15e-05	0.000253	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOA4—atherosclerosis	1.15e-05	0.000252	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.14e-05	0.000251	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP7A1—atherosclerosis	1.13e-05	0.000248	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PPARG—atherosclerosis	1.13e-05	0.000247	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	1.13e-05	0.000247	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—BGN—atherosclerosis	1.12e-05	0.000246	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.12e-05	0.000246	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP27A1—atherosclerosis	1.12e-05	0.000245	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ESR1—atherosclerosis	1.11e-05	0.000245	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.11e-05	0.000244	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOA5—atherosclerosis	1.11e-05	0.000244	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ABCA1—atherosclerosis	1.11e-05	0.000243	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—INS—atherosclerosis	1.1e-05	0.000243	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—F2—atherosclerosis	1.1e-05	0.000242	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	1.09e-05	0.00024	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	1.09e-05	0.00024	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.08e-05	0.000237	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	1.07e-05	0.000236	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PLA2G1B—atherosclerosis	1.07e-05	0.000235	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOA2—atherosclerosis	1.06e-05	0.000232	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PLA2G2A—atherosclerosis	1.06e-05	0.000232	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALOX5AP—atherosclerosis	1.06e-05	0.000232	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALOX15—atherosclerosis	1.06e-05	0.000232	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.06e-05	0.000232	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PIK3CG—atherosclerosis	1.05e-05	0.000231	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.05e-05	0.00023	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ABCG5—atherosclerosis	1.04e-05	0.000229	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.04e-05	0.000229	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP27A1—atherosclerosis	1.04e-05	0.000229	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALOX5—atherosclerosis	1.03e-05	0.000227	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	1.03e-05	0.000225	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.02e-05	0.000224	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ALB—atherosclerosis	1.01e-05	0.000222	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—MAPK3—atherosclerosis	1.01e-05	0.000222	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—LPA—atherosclerosis	1.01e-05	0.000221	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	1e-05	0.00022	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—INS—atherosclerosis	9.97e-06	0.000219	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	9.88e-06	0.000217	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	9.88e-06	0.000217	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALOX15—atherosclerosis	9.88e-06	0.000217	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOA2—atherosclerosis	9.88e-06	0.000217	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCL2—atherosclerosis	9.81e-06	0.000216	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—BGN—atherosclerosis	9.77e-06	0.000215	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ABCG5—atherosclerosis	9.75e-06	0.000214	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	9.74e-06	0.000214	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—NOS3—atherosclerosis	9.69e-06	0.000213	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOA5—atherosclerosis	9.67e-06	0.000212	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IGF1—atherosclerosis	9.65e-06	0.000212	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	9.53e-06	0.000209	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—HMOX1—atherosclerosis	9.5e-06	0.000209	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—LPA—atherosclerosis	9.42e-06	0.000207	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PLA2G1B—atherosclerosis	9.31e-06	0.000204	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NAMPT—atherosclerosis	9.25e-06	0.000203	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	9.22e-06	0.000203	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	9.2e-06	0.000202	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—LIPC—atherosclerosis	9.2e-06	0.000202	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SERPINE1—atherosclerosis	9.16e-06	0.000201	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOC3—atherosclerosis	9.14e-06	0.000201	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—BGN—atherosclerosis	9.12e-06	0.0002	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—APOB—atherosclerosis	9.1e-06	0.0002	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—LDLR—atherosclerosis	9.08e-06	0.000199	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	9.06e-06	0.000199	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOA5—atherosclerosis	9.03e-06	0.000198	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALOX5—atherosclerosis	8.99e-06	0.000197	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CETP—atherosclerosis	8.87e-06	0.000195	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PTGS2—atherosclerosis	8.86e-06	0.000195	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GSTM1—atherosclerosis	8.85e-06	0.000194	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	8.77e-06	0.000193	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NOS3—atherosclerosis	8.75e-06	0.000192	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	8.69e-06	0.000191	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—LPL—atherosclerosis	8.69e-06	0.000191	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	8.65e-06	0.00019	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	8.6e-06	0.000189	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	8.52e-06	0.000187	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	8.5e-06	0.000187	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SCARB1—atherosclerosis	8.5e-06	0.000187	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GPX1—atherosclerosis	8.48e-06	0.000186	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALOX5—atherosclerosis	8.4e-06	0.000184	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	8.27e-06	0.000182	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CD36—atherosclerosis	8.25e-06	0.000181	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NAMPT—atherosclerosis	8.06e-06	0.000177	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—HMGCR—atherosclerosis	8.02e-06	0.000176	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—LIPC—atherosclerosis	8.01e-06	0.000176	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOC3—atherosclerosis	7.96e-06	0.000175	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—LDLR—atherosclerosis	7.91e-06	0.000174	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—MTHFR—atherosclerosis	7.82e-06	0.000172	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CXCL8—atherosclerosis	7.76e-06	0.00017	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	7.76e-06	0.00017	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CETP—atherosclerosis	7.73e-06	0.00017	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPARA—atherosclerosis	7.67e-06	0.000169	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	7.59e-06	0.000167	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NAMPT—atherosclerosis	7.53e-06	0.000165	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—AKT1—atherosclerosis	7.49e-06	0.000165	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	7.49e-06	0.000164	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—LIPC—atherosclerosis	7.48e-06	0.000164	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOC3—atherosclerosis	7.44e-06	0.000163	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—AGT—atherosclerosis	7.43e-06	0.000163	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SCARB1—atherosclerosis	7.4e-06	0.000163	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—LDLR—atherosclerosis	7.39e-06	0.000162	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL6—atherosclerosis	7.38e-06	0.000162	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—APOE—atherosclerosis	7.28e-06	0.00016	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.24e-06	0.000159	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CETP—atherosclerosis	7.22e-06	0.000159	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CAV1—atherosclerosis	7.21e-06	0.000158	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—APOA1—atherosclerosis	7.2e-06	0.000158	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ABCA1—atherosclerosis	7.15e-06	0.000157	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MMP9—atherosclerosis	7.02e-06	0.000154	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HMGCR—atherosclerosis	6.99e-06	0.000154	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NFKB1—atherosclerosis	6.94e-06	0.000152	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SCARB1—atherosclerosis	6.91e-06	0.000152	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	6.85e-06	0.000151	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MAPK8—atherosclerosis	6.82e-06	0.00015	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—AKT1—atherosclerosis	6.81e-06	0.000149	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	6.73e-06	0.000148	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PIK3CG—atherosclerosis	6.57e-06	0.000144	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HMGCR—atherosclerosis	6.53e-06	0.000143	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPARG—atherosclerosis	6.34e-06	0.000139	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—VEGFA—atherosclerosis	6.3e-06	0.000138	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—STAT3—atherosclerosis	6.24e-06	0.000137	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ABCA1—atherosclerosis	6.23e-06	0.000137	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—INS—atherosclerosis	6.22e-06	0.000137	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—HMOX1—atherosclerosis	6.14e-06	0.000135	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MAPK3—atherosclerosis	5.96e-06	0.000131	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.89e-06	0.000129	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOB—atherosclerosis	5.88e-06	0.000129	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ABCA1—atherosclerosis	5.82e-06	0.000128	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TGFB1—atherosclerosis	5.78e-06	0.000127	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTM1—atherosclerosis	5.72e-06	0.000126	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ALB—atherosclerosis	5.7e-06	0.000125	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—LPL—atherosclerosis	5.61e-06	0.000123	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GPX1—atherosclerosis	5.47e-06	0.00012	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—NOS3—atherosclerosis	5.46e-06	0.00012	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HMOX1—atherosclerosis	5.35e-06	0.000117	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CD36—atherosclerosis	5.33e-06	0.000117	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOB—atherosclerosis	5.12e-06	0.000112	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—MTHFR—atherosclerosis	5.05e-06	0.000111	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HMOX1—atherosclerosis	4.99e-06	0.00011	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PTGS2—atherosclerosis	4.99e-06	0.00011	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTM1—atherosclerosis	4.98e-06	0.000109	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPARA—atherosclerosis	4.96e-06	0.000109	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—LPL—atherosclerosis	4.89e-06	0.000107	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—AGT—atherosclerosis	4.8e-06	0.000105	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOB—atherosclerosis	4.78e-06	0.000105	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GPX1—atherosclerosis	4.77e-06	0.000105	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOE—atherosclerosis	4.7e-06	0.000103	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CAV1—atherosclerosis	4.66e-06	0.000102	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTM1—atherosclerosis	4.65e-06	0.000102	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOA1—atherosclerosis	4.65e-06	0.000102	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CD36—atherosclerosis	4.65e-06	0.000102	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—LPL—atherosclerosis	4.57e-06	0.0001	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GPX1—atherosclerosis	4.46e-06	9.79e-05	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—AKT1—atherosclerosis	4.45e-06	9.78e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—MTHFR—atherosclerosis	4.4e-06	9.67e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL6—atherosclerosis	4.36e-06	9.57e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CD36—atherosclerosis	4.34e-06	9.53e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPARA—atherosclerosis	4.32e-06	9.48e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PIK3CG—atherosclerosis	4.24e-06	9.32e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—AGT—atherosclerosis	4.18e-06	9.19e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—MTHFR—atherosclerosis	4.11e-06	9.03e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOE—atherosclerosis	4.1e-06	9e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPARG—atherosclerosis	4.1e-06	9e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CAV1—atherosclerosis	4.06e-06	8.92e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOA1—atherosclerosis	4.05e-06	8.9e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPARA—atherosclerosis	4.03e-06	8.86e-05	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—AKT1—atherosclerosis	4.02e-06	8.83e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—INS—atherosclerosis	4.02e-06	8.83e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—AGT—atherosclerosis	3.91e-06	8.58e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOE—atherosclerosis	3.83e-06	8.41e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CAV1—atherosclerosis	3.79e-06	8.33e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOA1—atherosclerosis	3.78e-06	8.31e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PIK3CG—atherosclerosis	3.7e-06	8.12e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALB—atherosclerosis	3.68e-06	8.09e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPARG—atherosclerosis	3.57e-06	7.84e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NOS3—atherosclerosis	3.52e-06	7.74e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—INS—atherosclerosis	3.5e-06	7.69e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PIK3CG—atherosclerosis	3.45e-06	7.59e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPARG—atherosclerosis	3.33e-06	7.32e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—INS—atherosclerosis	3.27e-06	7.18e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PTGS2—atherosclerosis	3.22e-06	7.08e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALB—atherosclerosis	3.21e-06	7.05e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NOS3—atherosclerosis	3.07e-06	6.74e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALB—atherosclerosis	3e-06	6.59e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NOS3—atherosclerosis	2.87e-06	6.3e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PTGS2—atherosclerosis	2.81e-06	6.17e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PTGS2—atherosclerosis	2.62e-06	5.76e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—AKT1—atherosclerosis	2.51e-06	5.51e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—AKT1—atherosclerosis	1.62e-06	3.56e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—AKT1—atherosclerosis	1.41e-06	3.1e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—AKT1—atherosclerosis	1.32e-06	2.9e-05	CbGpPWpGaD
